Mechanism of interaction of sitamaquine with Leishmania donovani.
OBJECTIVE
This study focuses on the mechanism of interaction of sitamaquine with Leishmania donovani membranes, and its accumulation within the parasites.


METHODS
A biomimetic model of the outer layer of a Leishmania plasma membrane was used to examine the interactions of sitamaquine with lipids. The plasma membranes of L. donovani promastigotes were depleted of sterol using cholesterol oxidase, in order to assess the importance of sterols in drug-membrane interactions. Sterols were quantiﬁed and sitamaquine susceptibility was assessed using the MTT test. Kinetics of sitamaquine accumulation and efflux were measured under different conditions.


RESULTS
Sitamaquine interacts first with phospholipid anionic polar head groups and then with phospholipid acyl chains to insert within biological membranes and accumulates rapidly in the Leishmania cytosol according to a sterol-independent process. The rapid sitamaquine efflux observed was related to an energy-dependent mechanism since the intracellular amount of sitamaquine was enhanced three times in the absence of glucose and the efflux was inhibited in energy-depleted conditions. (1)H NMR analysis of motile lipid showed that sitamaquine did not affect lipid trafficking in Leishmania.


CONCLUSIONS
We propose that sitamaquine rapidly accumulates in Leishmania by diffusion along an electrical gradient and is concentrated in the cytosol by an energy- and sterol-independent process. The affinity of sitamaquine for membranes was transitory and an energy-dependent efflux was demonstrated, suggesting the presence of an as yet uncharacterized transporter.
Coimbra
E S
ES
Université Paris-Sud, UMR 8076, Chimiothérapie Antiparasitaire, Faculté de Pharmacie, Chatenay-Malabry, France.
Libong
D
D
Cojean
S
S
Saint-Pierre-Chazalet
M
M
Solgadi
A
A
Le Moyec
L
L
Duenas-Romero
A M
AM
Chaminade
P
P
Loiseau
P M
PM
D000634:Aminoquinolines / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D000981:Antiprotozoal Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D040761:Biomimetic Materials / Q000737:chemistry / Q000378:metabolism; D002462:Cell Membrane / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D004058:Diffusion; D007893:Leishmania donovani / Q000187:drug effects* / Q000378:metabolism; D008563:Membrane Lipids / Q000737:chemistry / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D013261:Sterols / Q000378:metabolism
D000634:Aminoquinolines; D000981:Antiprotozoal Agents; D008563:Membrane Lipids; D010743:Phospholipids; D013261:Sterols; C080436:8-aminoquinoline